1. Home
  2. RYI vs TRVI Comparison

RYI vs TRVI Comparison

Compare RYI & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYI
  • TRVI
  • Stock Information
  • Founded
  • RYI 1842
  • TRVI 2011
  • Country
  • RYI United States
  • TRVI United States
  • Employees
  • RYI N/A
  • TRVI N/A
  • Industry
  • RYI Metal Fabrications
  • TRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • RYI Industrials
  • TRVI Health Care
  • Exchange
  • RYI Nasdaq
  • TRVI Nasdaq
  • Market Cap
  • RYI 699.3M
  • TRVI 725.7M
  • IPO Year
  • RYI N/A
  • TRVI 2019
  • Fundamental
  • Price
  • RYI $22.80
  • TRVI $7.98
  • Analyst Decision
  • RYI Hold
  • TRVI Strong Buy
  • Analyst Count
  • RYI 1
  • TRVI 9
  • Target Price
  • RYI $25.00
  • TRVI $20.72
  • AVG Volume (30 Days)
  • RYI 190.2K
  • TRVI 3.1M
  • Earning Date
  • RYI 10-28-2025
  • TRVI 11-05-2025
  • Dividend Yield
  • RYI 3.24%
  • TRVI N/A
  • EPS Growth
  • RYI N/A
  • TRVI N/A
  • EPS
  • RYI N/A
  • TRVI N/A
  • Revenue
  • RYI $4,439,000,000.00
  • TRVI N/A
  • Revenue This Year
  • RYI $0.20
  • TRVI N/A
  • Revenue Next Year
  • RYI $3.78
  • TRVI N/A
  • P/E Ratio
  • RYI N/A
  • TRVI N/A
  • Revenue Growth
  • RYI N/A
  • TRVI N/A
  • 52 Week Low
  • RYI $17.18
  • TRVI $2.36
  • 52 Week High
  • RYI $27.41
  • TRVI $9.92
  • Technical
  • Relative Strength Index (RSI)
  • RYI 52.83
  • TRVI 52.21
  • Support Level
  • RYI $21.87
  • TRVI $7.65
  • Resistance Level
  • RYI $22.69
  • TRVI $8.28
  • Average True Range (ATR)
  • RYI 0.71
  • TRVI 0.69
  • MACD
  • RYI 0.01
  • TRVI 0.02
  • Stochastic Oscillator
  • RYI 51.14
  • TRVI 35.12

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: